Generic drugs bring down costs in poorest countries
Wednesday 01 December 2010
Responding to criticism of the high cost of HIV drugs, pharma firms have spent the past decade stepping up efforts to improve access to treatments in poorer countries.
Initiatives range from heavy discounts in certain parts of the world to royalty-free licences which allow others to produce generics or cheap copies of the original drugs.
The market leader, Gilead Sciences, runs an access programme that provides drugs at steep discounts in some 130 countries. The company runs a tiered pricing system, with prices determined by a country's economic strength and the prevalence of HIV.
Gilead also provides non-exclusive licences to Indian generic manufacturers, but charges a 5 per cent royalty on sales based on the price of the generic drugs. ViiV Healthcare provides drugs at not-for-profit prices and through royalty-free voluntary licences. Last year, ViiV shipped 11.7 million tablets of its Combivir and 21 million tablets of its Epivir treatments at not-for-profit prices. Although lower than in 2008, the decline was more than offset by growing volumes from ViiV's licensees. Bristol-Myers Squibb and Merck also run various access initiatives around the world.
The efforts, coupled with the growth in generics and other factors, have brought down the cost of initial or first-line treatments in poorer countries.
But former UN special envoy for HIV/Aids in Africa Stephen Lewis points out that second- and third-line treatments remain expensive, a point also raised by Michelle Childs, health policy adviser for the Médecins Sans Frontières Access to Essential Medicines campaign.
- 1 Jeremy Clarkson 'sees no problem' with his racist language on Top Gear, says BBC
- 2 'Alien thigh bone' on Mars: Excitement from alien hunters at 'evidence' of extraterrestrial life
- 4 London restaurant 34 creates champagne glass modelled on Kate Moss’ left breast
- 5 ALS ice bucket challenge co-founder Corey Griffin drowns, aged 27
'Alien thigh bone' on Mars: Excitement from alien hunters at 'evidence' of extraterrestrial life
Russell Brand opposes anti-Semitism after death threats: 'We must disavow all forms of prejudice that lead to exclusion and execution'
James Foley 'beheaded': Isis video shows militant with British accent 'execute US journalist' – as hunt begins for killer
ALS ice bucket challenge co-founder Corey Griffin drowns, aged 27
Microbial life found living on the exterior of the International Space Station, say reports
Richard Dawkins on babies with Down Syndrome: 'Abort it and try again – it would be immoral to bring it into the world'
Scottish independence: English people overwhelmingly want Scotland to stay in the UK
Isis threat: Cameron wants an alliance with Iran
Michael Brown shooting: Chaos erupts on the streets of Ferguson after autopsy shows teenager was shot six times – twice in the head
Bin bag full of cats' heads discovered near Manchester's Curry Mile
Disgusting, frustrating, but intriguing: how the country really feels about its politicians
iJobs Money & Business
£30000 - £40000 per annum + benefits+bonus+package: Harrington Starr: C#.NET ...
£20000 - £30000 per annum + benefits+bonus+package: Harrington Starr: Junior D...
£550 - £650 per day: Orgtel: Business Analyst - Traded Credit Risk - Investmen...
£55000 per annum: Harrington Starr: A financial software vendor at the forefro...